ELISA Products & Reviews

The myelin basic protein (MBP) enzyme linked immunuosorbent assay (ELISA) kit provides materials for the quantitative measurement of MBP in cerebrospinal fluid

Pregnancy associated plasma protein-A2 (PAPP-A2) is a novel metalloproteinase identified as a homolog of PAPP-A in the metzincin superfamily of pappalysins. PAPP-A2 shares 46% sequence identity with PAPP-A. PAPP-A2 is a noncovalently linked dimer of two 220-kDa subunits. It exhibits robust proteolytic activity against IGFBP-5 and possibly also IGFBP-3.  PAPP-A2 is expressed in a wide range of tissues and is abundant in placent…

The Ansh Labs' Equine Anti-Müllerian hormone (AMH) enzyme-linked immunosorbent assay (ELISA) kit is the only AMH assay designed specifically for use in horses. Multiple validation studies have shown excellent distinction between castrated geldings and intact stallions. AMH is also an excellent tool in the evaluation of equine granulosa cell tumors (GCT) and cryptochordism.  

The Ansh Labs' Canine Anti-Müllerian hormone (AMH) enzyme-linked immunosorbent assay (ELISA) kit is the only AMH assay designed specifically for use in canine. AMH measurements in canines are particularly useful in confirming that spay procedures have been done correctly leaving no remnant ovarian tissue.  

The Follistatin enzyme linked immunosorbent assay (ELISA) kit provides materials for the quantitative measurement of total follistatin (288, 300, 315) in human serum and other biological fluids.

IGFBP-3 exhibits intrinsic growth-regulating effects that are not yet fully understood, but have evoked interest with regards to a possible role of IGFBP-3 as a prognostic tumor marker. Low IGFBP-3 and IGF-I levels are observed in GH deficiency or GH resistance, also epidemiologic studies suggest that low IGFBP-3 is associated with greater risk of aggressive, metastatic prostate cancers. 

The Total IGFBP-5 enzyme linked immunosorbent assay (ELISA) kit provides materials for the quantitative measurement of IGFBP-5 in human serum and other biological fluids

Several studies have shown that concentration of PAPP-A in blood of patients with acute coronary syndrome (ACS) is higher than in blood of patients with stable coronary artery disease or control subjects. PAPP-A has been suggested as a marker of cardiovascular diseases associated with coronary artery blood clotting, such as unstable angina and myocardial infarction (MI). 

Dried blood spot specimens stability makes it a practical alternative to venous blood. It opens new possibilities in AMH testing, such as comparison of historical to current patient results; simplified blood sampling for patients in remote locations or for those who are homebound. Instead of traveling to a clinic to get blood drawn, a blood spot sample can be taken at a convenient site and mailed to a laboratory. 

The Insulin-Like Growth Factor II (IGF-II) enzyme linked immunosorbent assay (ELISA) kit provides materials for the quantitative measurement of IGF-II in serum and other biological fluids